Congestive Heart Failure: Clinical Trials

49 trials for Congestive Heart Failure, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

49 completed. 49 Phase 2, 10 Phase 1, 8 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 249Completed 49
Phase 110Completed 10
Phase 38Completed 8

Follow Congestive Heart Failure: new trials by email Literature Review of Congestive Heart Failure trials Research Report on Congestive Heart Failure

Trials (filtered) newest first · largest first

All 49 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
An Investigational Study of Continuous 8-Hour Intravenous Administrations of BMS-986231 in Participants With Heart Failure and Reduced Heart Function Given a Standard Dose of Loop Diuretic
BMS-986231, Furosemide, Placebo - Cardiac Failure, Myocardial Failure
Phase 2CompletedBristol-Myers Squibb232019-01-172021-02-26
Regression of Fibrosis & Reversal of Diastolic Dysfunction in HFpEF Patients Treated With Allogeneic CDCs
Allogeneic Derived Cells, Placebo/Control Arm - Congestive Heart Failure, Heart Failure, Diastolic
Phase 2CompletedCedars-Sinai Medical Center272017-07-122024-07-25
Sub-Q Versus IV Furosemide in Acute Heart Failure
Furosemide Injection Solution (SCP-101), Furosemide Injection Solution, USP - Congestive Heart Failure
Phase 2 / Phase 3CompletedJohns Hopkins University402016-02-012017-12-18
The Use of Intranasal Fentanyl for the Treatment of Incident Dyspnea in Congestive Heart Failure: A Prospective Trial
fentanyl - Dyspnea, Congestive Heart Failure
Phase 2CompletedSt. Boniface Hospital82015-10-012017-09-28
Vitamin D3 Supplementation for Heart Failure Patients
Placebo Comparator: Sugar Pill, Vitamin D3 (cholecalciferol) - Heart Failure, Vitamin D Deficiency
Phase 2CompletedHeidi Moretti, MS, RD402012-08-012017-04-26
Autonomic Neural Regulation Therapy to Enhance Myocardial Function in Heart Failure (ANTHEM-HF) Study
Vagus Nerve Stimulation (VNS) - Congestive Heart Failure
Phase 1 / Phase 2CompletedCyberonics, Inc.602012-07-012015-02-19
Tadalafil and Nesiritide as Therapy in Pre-clinical Heart Failure
Nesiritide, Tadalafil, Placebo - Congestive Heart Failure
Phase 1 / Phase 2CompletedMayo Clinic432012-02-012018-03-22
Vasodilator Therapy for Heart Failure and Preserved Ejection Fraction
Isosorbide Dinitrate, Isosorbide Dinitrate + Hydralazine, Placebo - Heart Failure, Congestive Heart Failure
Phase 2CompletedCorporal Michael J. Crescenz VA Medical Center442012-01-012022-06-21
Liraglutide and Heart Failure in Type 2 Diabetes
liraglutide, glimepiride, Metformin - Congestive Heart Failure, Type 2 Diabetes Mellitus
Phase 2CompletedThomas Nystrom622012-01-012016-09-01
Blood Pressure Reduction in Heart Failure
Hydralazine/amlodipine, Placebo - Heart Failure, Cardiac Failure
Phase 2 / Phase 3CompletedUniversity of Sao Paulo212011-01-012014-06-10
Safety Study of GE-145 320 mg I/mL Injection vs. Iopamidol 370 mg I/mL in Elderly Subjects Undergoing Coronary Procedure
GE-145 - Chronic Renal Insufficiency, Diabete Mellitus
Phase 2CompletedGE Healthcare2842010-11-012018-08-29
Care Guides in the Primary Care Office (Phase II)
education and care guide, education only - Diabetes, Hypertension
Phase 2CompletedAllina Health System21352010-07-012019-04-08
AC6 Gene Transfer for CHF
Ad5.hAC6, Sucrose (3%) - Congestive Heart Failure
Phase 1 / Phase 2CompletedHammond, H. Kirk, M.D.562010-07-012018-02-09
Study to Evaluate the Effects of Oral Administration of Lixivaptan in Patients With Congestive Heart Failure
Lixivaptan, Placebo - Congestive Heart Failure
Phase 2CompletedCardioKine Inc.1702010-01-012011-06-28
Evaluation of a Diagnostic Feature in a Cardiac Resynchronization Therapy (CRT) Device
Paradym CRT + Physiological Diagnosis (PhD) - Congestive Heart Failure
Phase 2CompletedELA Medical, Inc.5202009-09-012014-05-15
Intensive Glycemic Control for Congestive Heart Failure Exacerbation
Intravenous insulin, Subcutaneous insulin - Congestive Heart Failure, Diabetes Mellitus
Phase 2CompletedKathleen Dungan742009-01-012018-01-02
Glycemic Control and Variability for Congestive Heart Failure Exacerbation
Intravenous insulin, Subcutaneous insulin - Congestive Heart Failure, Diabetes Mellitus
Phase 1 / Phase 2CompletedKathleen Dungan752009-01-012013-12-31
Autologous Mesenchymal Stromal Cell Therapy in Heart Failure
Mesenchymal stromal cell, Saline - Congestive Heart Failure
Phase 1 / Phase 2CompletedCopenhagen University Hospital, Rigshospitalet592008-09-012015-03-17
Efficiency Study of Triple-Site Cardiac Resynchronization in Patients With Heart Failure
Cardiac resynchronization pacemaker (InSync Sentry or Concerto, Medtronic, Minneapolis, MN,USA) with two intracardiac leads, Triple-site cardiac resynchronization - Congestive Heart Failure, Heart Disease
Phase 2 / Phase 3CompletedSilesian Centre for Heart Diseases1002008-02-012016-04-13
Interventricular Delay of Lumax HF-T for Heart Failure
Optimized interventricular delay biventricular pacing - Congestive Heart Failure
Phase 2CompletedBiotronik, Inc.1222007-07-012010-01-26

Showing 20 of 49. Sign in to see all of them.

Narrower conditions

Heart Failure (49)  ·  Diabetes Mellitus (5)  ·  Renal Insufficiency (3)  ·  Anemia (2)  ·  Cardiomyopathies (2)  ·  Hyperglycemia (2)  ·  Myocardial Infarction (2)  ·  Myocardial Ischemia (2)  ·  Adenoviridae Infections (1)  ·  Angina Pectoris (1)  ·  Angina, Unstable (1)  ·  Chest Pain (1)  ·  Chronic Disease (1)  ·  Coronary Disease (1)  ·  Diabetes Mellitus, Type 2 (1)

Broader conditions

Cardiovascular Diseases (49)  ·  Heart Diseases (48)  ·  Nutritional and Metabolic Diseases (8)  ·  Glucose Metabolism Disorders (7)  ·  Metabolic Diseases (7)  ·  Pathological Conditions, Signs and Symptoms (7)  ·  Endocrine System Diseases (6)  ·  Pathologic Processes (5)  ·  Female Urogenital Diseases (4)  ·  Female Urogenital Diseases and Pregnancy Complications (4)  ·  Kidney Diseases (4)  ·  Male Urogenital Diseases (4)  ·  Signs and Symptoms (4)  ·  Urogenital Diseases (4)  ·  Urologic Diseases (4)

Interventions

Natriuretic Peptide, Brain (5)  ·  Darbepoetin alfa (2)  ·  Furosemide (2)  ·  Hydralazine (2)  ·  Sodium Chloride (2)  ·  Tolvaptan (2)  ·  5-(formyl-(3-(formyl-(3,5-bis (2,3-dihydroxypropylcarbamoyl)-2,4,6-triiodophenyl) amino)-2-hydroxypropyl)amino)-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodobenzene-1,3-dicarboxamide (1)  ·  Acupuncture Therapy (1)  ·  Allopurinol (1)  ·  Amlodipine (1)  ·  Cardiac Resynchronization Therapy (1)  ·  Cholecalciferol (1)  ·  Defibrillators (1)  ·  Educational Status (1)  ·  Endothelium-Dependent Relaxing Factors (1)

Sponsors

Boston Scientific Corporation (3)  ·  Amgen (2)  ·  Horng Chen (2)  ·  Johns Hopkins University (2)  ·  Kathleen Dungan (2)  ·  Otsuka Pharmaceutical Development & Commercialization, Inc. (2)  ·  Advanz Pharma (1)  ·  Allina Health System (1)  ·  AstraZeneca (1)  ·  Bio-Medisinsk Innovasjon (1)  ·  Biotronik, Inc. (1)  ·  Brigham and Women's Hospital (1)  ·  Bristol-Myers Squibb (1)  ·  CardioKine Inc. (1)  ·  Cedars-Sinai Medical Center (1)

Countries

United States (32)  ·  Germany (4)  ·  United Kingdom (3)  ·  Canada (2)  ·  Denmark (2)  ·  Brazil (1)  ·  India (1)  ·  Norway (1)  ·  Poland (1)  ·  Sweden (1)  ·  Switzerland (1)

Top investigators

Horng H. Chen, M.D. (2)  ·  Kathleen M Dungan, MD (2)  ·  Amit Patel, MD (1)  ·  Andreas M Zeiher, MD (1)  ·  Anju Nohria, MD (1)  ·  Boris Nasseri, MD (1)  ·  Bradley D Berry, MD (1)  ·  Christian Torp-Pedersen, Dr. Med (1)  ·  Christof Stamm, MD (1)  ·  Clyde W Yancy, MD (1)  ·  David R Murray, MD (1)  ·  Dirk H Walter, MD (1)  ·  Edimar A Bocchi, Prof. (1)

Results publications

PMID 15152059, PMID 15319045, PMID 16796497, PMID 17543634, PMID 18549913, PMID 19204305, PMID 19567409, PMID 19919976, PMID 21411144, PMID 22156953, PMID 22361399, PMID 22510424, PMID 22651239, PMID 22728580, PMID 22936827, PMID 22980293, PMID 23122795, PMID 23487543, PMID 23592107, PMID 23922063, PMID 24497345, PMID 24626998, PMID 25187002, PMID 25319879, PMID 25926562, PMID 26601770, PMID 27221316, PMID 27437887, PMID 28219917, PMID 29084522, PMID 29226816, PMID 29548934, PMID 30764699, PMID 31168885, PMID 31909303, PMID 33590355, PMID 34405565, PMID 34920733, PMID 35360224, PMID 35490339, PMID 37349083

NIH funding

P01HL076611 (3), UL1RR024150 (3), R01HL084155 (2), 2004 (1), 2005 (1), 2018 (1), K23DK080891 (1), P01HL066941 (1), R01HL036634 (1), R01HL061912 (1), R21AG043802 (1), R21DK081877 (1)